This is unpublished

Terry B.
Gernsheimer
M.D.

Terry Gernsheimer
Physician & Research Faculty
Pinned
Academic
Professor Emeritus, Division of Hematology and Oncology, University of Washington

Education and training

  • M.D., State University of New York at Stony Brook
  • Residency in Internal Medicine, New England Deaconess Hospital
  • Fellowship in Hematology, University of Washington

publications

PubMed

research and/or clinical career

Dr. Terry Gernsheimer contributed broadly to the areas of platelet biology, thrombocytopenia, transfusion and platelet immunology. Importantly, she showed that immune thrombocytopenia (ITP) was a disease of poor platelet production as well as peripheral platelet destruction, providing the physiological basis for thrombopoietin mimetic therapy, and then helped show the therapeutic efficacy of thrombopoietin mimetics (eltrombopag, avatrombopag and romiplostim). She also helped define causes of thrombocytopenia in pregnancy, helped optimize platelet and red cell transfusion strategies, and studied prophylactic tranexamic acid in preventing bleeding. Dr. Gernsheimer served as Councilor to the American Society of Hematology (ASH) and as member and chair of ASH, National Institutes of Health (NHLBI) and American Association of Blood Bank (AABB) committees on platelet biology, clinical trials, transfusion guidelines and ITP. Locally, Dr. Gernsheimer chaired the UW medical student hematology course, was multiply recognized as a Top Doctor by Seattle Met and Seattle Magazine, was Director of Medical Transfusion Services at the UW Medical Center, Medical Director of Transfusion at the Seattle Cancer Care Alliance (n/k/a Fred Hutch) and Medical Director for the Platelet Immunology Laboratory at Blood Works Northwest (BWNW).